Napredna pretraga

Pregled bibliografske jedinice broj: 197042

Detection of the substance immunologically cross-reactive with insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme


Šarić, Tomo; Seitz, Hans Joachim; Pavelić, Krešimir
Detection of the substance immunologically cross-reactive with insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme // Molecular and cellular endocrinology, 106 (1994), 1-2; 23-29 (međunarodna recenzija, članak, znanstveni)


Naslov
Detection of the substance immunologically cross-reactive with insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme

Autori
Šarić, Tomo ; Seitz, Hans Joachim ; Pavelić, Krešimir

Izvornik
Molecular and cellular endocrinology (0303-7207) 106 (1994), 1-2; 23-29

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Insulin; RIA; cross-reactive

Sažetak
In previous literature, the existence of a new insulin-like substance found in tumor tissues, termed substance immunologically cross-reactive with insulin (SICRI), has been proposed. In these studies, insulin-specific radioimmunoassay (RIA) was the only detection method for SICRI. The mouse melanoma B16BL6 cell line was found to be a rich source of SICRI. In this paper, we show that SICRI is not expressed in B16BL6 cells. Previous RIA measurements were wrongly ascribed to SICRI. What was really measured was a positive artifact caused by insulin tracer degradation in RIA. Several lines of evidence indicate that protease responsible for insulin degradation in B16BL6 cells is insulin-degrading enzyme (IDE ; EC 3.4.22.11). First, SICRI activity of B16BL6 cytosol measured by insulin RIA was inhibited by thiol protease inhibitor N-ethylmaleimide (NEM). Thiol active agents as well as metal chelators, both potent IDE blockers, inhibited also the insulin-degrading activity of the same sample. Second, cross-linking to I-125-labeled insulin of partially purified sample with highest insulin RIA activity specifically labeled only a single protein with molecular mass similar to IDE (110 kDa). Labeling was blocked by 'cold' insulin in excess. Third, kinetic studies of insulin degradation by RIA active chromatographic fractions revealed an apparent K-d of 90 nM which is very similar to the reported affinity of insulin for IDE (K-d = 100 nM). Additionally, in B16BL6 as well as in mouse myeloid leukemia cells, IDE gene is actively transcribed and this expression was found to be much stronger than in normal mouse tissues. In conclusion, our results strongly question the real existence of SICRI. They showed that IDE is responsible for false positive measurements of SICRI in RIA. These artifacts were circumvented by IDE inhibitor NEM. Finally, increased expression of IDE gene in mouse tumor tissues suggests a possible important role for IDE in the process of malignant transformation.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove
Institut "Ruđer Bošković", Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE